```html

Yellowing of the Eyes (Icteric Sclera)

What is Yellowing of the eyes (icteric sclera)?

Yellowing of the eyes, medically called icteric sclera, occurs when the normally white part of the eye (the sclera) takes on a yellow hue. The discoloration is caused by a buildup of a pigment called bilirubin in the bloodstream, which then deposits in connective tissue, including the sclera. Because the sclera is thin and highly vascular, changes in bilirubin level become visible earlier here than on the skin.

While a faint yellow tint may be harmless in some contexts, icteric sclera is often a visual clue that something is affecting the liver, gallbladder, or red blood cells. Recognizing it early can prompt timely evaluation and treatment.

Common Causes

The following conditions are among the most frequent reasons for icteric sclera. Some are acute and self‑limited; others are chronic and require long‑term management.

• Hepatitis (viral, alcoholic, drug‑induced) – Inflammation damages liver cells, reducing bilirubin clearance.
• Gallstones or Biliary Obstruction – Blockage of the bile ducts prevents bilirubin from being excreted.
• Alcoholic Liver Disease (cirrhosis) – Chronic alcohol damage impairs liver function.
• Non‑alcoholic Fatty Liver Disease (NAFLD) / NASH – Metabolic syndrome–related fat accumulation can progress to cirrhosis.
• Hemolytic Anemia – Accelerated breakdown of red blood cells releases excess bilirubin.
• Genetic Disorders (e.g., Gilbert’s syndrome, Crigler‑Najjar) – Enzyme defects reduce bilirubin conjugation.
• Medication‑induced Liver Injury – Acetaminophen overdose, certain antibiotics, antiretrovirals, and statins can cause toxic hepatitis.
• Pancreatic Cancer or Cholangiocarcinoma – Tumors in the pancreas or bile ducts may obstruct bile flow.
• Sepsis or Shock – Poor perfusion to the liver decreases its ability to process bilirubin.
• Newborn Physiologic Jaundice – Common in infants during the first week of life; usually resolves spontaneously.

Associated Symptoms

Yellowing of the sclera rarely occurs in isolation. Look for the following signs, which can help narrow the underlying cause:

• Yellowing of the skin (particularly on the palms and under the eyes)
• Dark urine (tea‑colored) and pale stools
• Abdominal pain—especially in the right upper quadrant
• Fatigue, weakness, or unexplained weight loss
• Itching (pruritus), especially on the palms and soles
• Fever or chills (suggesting infection)
• Joint pain or swelling (seen in some hemolytic disorders)
• Confusion or altered mental status (hepatic encephalopathy)

When to See a Doctor

Prompt medical evaluation is essential when any of the following are present:

• The yellow discoloration is new or rapidly progressing.
• You also have dark urine, pale stools, or itching.
• There is abdominal pain, especially if it’s severe, persistent, or accompanied by vomiting.
• You feel unusually tired, confused, or notice a change in mental alertness.
• Fever, chills, or a rapid heart rate develop.
• You have a known liver condition and notice worsening yellowing.
• Children or infants develop icteric sclera—particularly after the first two weeks of life.

Diagnosis

Doctors use a combination of history, physical examination, and targeted tests to identify the cause of icteric sclera.

1. Medical History & Physical Exam

• Detailed questioning about alcohol use, medication/supplement intake, recent travel, family history of liver disease, and exposure to hepatitis viruses.
• Physical exam focuses on liver size, tenderness, presence of ascites, and signs of chronic liver disease (spider angiomata, palmar erythema).

2. Laboratory Tests

• Complete Blood Count (CBC) – Detects anemia or infection.
• Liver Function Panel – Includes ALT, AST, ALP, GGT, bilirubin (total and direct), and albumin.
• Coagulation Studies (INR/PT) – Assess liver synthetic function.
• Hemolysis Work‑up – Haptoglobin, LDH, reticulocyte count, peripheral smear.
• Viral Hepatitis Serologies – Hepatitis A, B, C, and sometimes E.
• Autoimmune Markers – ANA, SMA, LKM‑1 if autoimmune hepatitis suspected.

3. Imaging Studies

• Abdominal Ultrasound – First‑line to look for gallstones, biliary dilation, or liver morphology.
• CT or MRI – Provide detailed anatomy when tumors or complex biliary disease are suspected.
• MRCP (Magnetic Resonance Cholangiopancreatography) – Non‑invasive visualization of the bile ducts.

4. Specialized Tests

• Liver Biopsy – Occasionally required to differentiate fibrosis, steatohepatitis, or infiltrative disease.
• Genetic Testing – For rare bilirubin‑processing disorders (e.g., Gilbert’s).

Treatment Options

Treatment is directed at the underlying cause. General supportive measures are also helpful.

1. Addressing the Primary Disease

• Viral Hepatitis – Antiviral therapy (e.g., sofosbuvir/velpatasvir for Hep C; tenofovir or entecavir for Hep B).
• Biliary Obstruction – Endoscopic removal of gallstones (ERCP) or surgical cholecystectomy.
• Alcohol‑Related Liver Disease – Complete abstinence, nutritional support, and possible corticosteroids for alcoholic hepatitis.
• NAFLD/NASH – Weight loss (5–10% of body weight), exercise, control of diabetes and hyperlipidemia, and in selected cases, vitamin E or pioglitazone under specialist care.
• Hemolytic Anemia – Treat trigger (e.g., stop offending drug), corticosteroids for autoimmune hemolysis, or transfusions if severe.
• Medication‑Induced Injury – Immediate discontinuation of the offending drug and monitoring; N‑acetylcysteine for acetaminophen overdose.
• Cancer‑related obstruction – Oncology‑guided chemotherapy, radiation, or surgical bypass.

2. Symptomatic & Supportive Care

• Hydration – Adequate oral fluids help the kidneys excrete bilirubin.
• Diet – Low‑fat, high‑protein diet with plenty of fruits and vegetables; avoid alcohol and excess fructose.
• Pruritus relief – Cholestyramine, rifampin, or antihistamines as directed.
• Vitamin K supplementation – If INR is elevated.
• Phototherapy – Used in severe newborn jaundice; not indicated for adults.

3. Follow‑up Care

Most patients require serial liver function tests every 1–3 months until bilirubin normalizes, then less frequently based on the chronicity of the disease.

Prevention Tips

While some causes (genetic disorders) cannot be prevented, many risk factors are modifiable:

• Limit alcohol intake to ≤ 1 drink per day for women and ≤ 2 drinks per day for men.
• Maintain a healthy weight (BMI < 25) through balanced diet and regular exercise.
• Vaccinate against hepatitis A and B.
• Practice safe sex and avoid sharing needles to reduce hepatitis C risk.
• Use medications only as prescribed; discuss liver‑friendly alternatives with your provider.
• Stay up‑to‑date on routine health screenings (e.g., liver ultrasound for high‑risk individuals).
• For newborns, ensure early feeding (breastfeeding or formula) to promote bilirubin excretion.

Emergency Warning Signs

If you experience any of the following, seek emergency medical care (call 911 or go to the nearest emergency department):

• Sudden, severe abdominal pain especially in the upper right quadrant.
• Rapid worsening of yellowing accompanied by confusion, drowsiness, or difficulty staying awake.
• Fever > 101 °F (38.3 °C) with chills.
• Vomiting blood or passing black, tarry stools.
• Sudden swelling of the abdomen or rapid weight gain (possible ascites).
• Shortness of breath or chest pain (could indicate heart failure secondary to liver disease).

Key Take‑aways

Icteric sclera is an important visual clue that bilirubin metabolism is impaired. While occasional mild yellowing may be benign, persistent or worsening discoloration signals an underlying medical condition that warrants evaluation. Early detection, appropriate laboratory testing, and targeted therapy can prevent complications and improve outcomes.

For further reading, see reputable sources such as the Mayo Clinic, CDC, and the NIH National Institute of Diabetes and Digestive and Kidney Diseases.

```